Table 1 Patient and tumour characteristics in the full cohort (n = 264)
Age | |
Mean | 67.29 |
Median | 69.00 |
Range | 46-84 |
Sex | |
Female | 135 (51.1%) |
Male | 129 (48.9%) |
Location | |
Head and neck | 17 (14.9%) |
Extremities | 111 (44.8%) |
Dorsal thorax | 65 (26.2%) |
Frontal thorax | 35 (14.1%) |
Unknown | 16 |
Clark level | |
II | 93 (37.7%) |
III | 103 (41.7%) |
IV | 44 (17.8%) |
V | 7 (2.8%) |
Unknown | 17 |
Breslow (mm) | |
Mean | 1.57 |
Median | 0.71 |
Range | 0.08-40.00 |
Breslow AJCC categories | |
< = 1 | 158 (59.8%) |
1-2 | 36 (13.6%) |
2-4 | 40 (15.2%) |
> 4 | 14 (5.3%) |
Unknown | 16 (6.1%) |
Clinical Stage | |
1A | 154 (74.4%) |
1B | 25 (12.1%) |
2A | 17 (8.2%) |
2B | 7 (3.4%) |
3A | 2 (1.0%) |
4 | 2 (1.0%) |
Unknown | 57 |
Histological type | |
SSM | 160 (64.5%) |
NMM | 53 (21.48%) |
LMM | 29 (11.7%) |
Other | 6 (2.4%) |
Unknown | 16 |
Ulceration | |
Absent | 214 (85.9%) |
Present | 35 (14.%) |
Unknown | 16 |
Mitotic count | |
< 1/mm2 | 131(51.8) |
> = 1/mm2 | 122(46.2) |
Lymphocytic infiltration | |
None-mild | 72 (29.0%) |
Moderate-high | 176 (66.7%) |
Unknown | 16 |
Recurrence | |
No | 217 (82.2%) |
Yes | 47 (17.8%) |
Follow-up (years) | |
Mean | 7.25 |
Median | 6.88 |
Range | 0.64-17.05 |
Vital status | |
Dead | 55 (20,8%) |
Alive | 219 (79,2%) |
Dead from malignant melanoma | 28 (10.6%) |